Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Latest Tuberculosis treatment Stories

2014-04-02 23:32:49

Presentation details three separate tuberculosis immunotherapies developed by Immunitor in collaboration with academic institutions and private companies in Mongolia, China, Thailand, Ukraine, UK, USA and Canada. Data presented support the Immunitor strategy to target inflammation as the main cause of TB and development of immunomodulators and therapeutic vaccines which demonstrate ability to rapidly clear TB, including MDR-TB and TB with HIV. Vancouver, BC, Canada (PRWEB) April 02, 2014...

2014-03-24 12:29:49

IBM's Big Data analytics to help crack the code of the tuberculosis genome and uncover new diagnosis and treatment approaches DURBAN, South Africa, March 24, 2014 /PRNewswire/ -- On World Tuberculosis Day, IBM (NYSE:IBM) and the KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH) have announced plans to research new treatment approaches to fight tuberculosis (TB) in South Africa. IBM's Big Data analytics technologies will be put to work on bacterial genetics and drug...

Bringing Attention To The Threat Of Tuberculosis On World TB Day
2014-03-24 07:49:51

Lawrence LeBlond for redOrbit.com - Your Universe Online Global partnerships and significant medical research are a big part of this year’s World Tuberculosis Day. Celebrated each year on March 24, World TB Day is a marked as a time to bring attention to the threat of tuberculosis, a disease that affects nearly nine million people a year. WHO For the World Health Organization (WHO), this year’s slogan for World TB Day is “Reach 3 Million.” Despite TB’s curability, efforts...

2014-03-20 12:33:41

Thousands receive treatment prior to coming to the United States ATLANTA, March 20, 2014 /PRNewswire-USNewswire/ -- Updated CDC recommendations for overseas tuberculosis (TB) screening of immigrants and refugees have identified hundreds of cases that otherwise would have gone undetected until after arrival in the United States, saving taxpayers an additional $15 million in medical costs. In 2012, the most recent year for which data are available, overseas physicians identified more...

2014-03-20 04:21:53

BEIJING and HILDEN, Germany, March 20, 2014 /PRNewswire/ -- - QuantiFERON-TB, the leading modern test for accurate diagnosis of latent tuberculosis infections, continues to grow rapidly around the world - Commercial launch of QuantiFERON-TB in China, where latent TB affects an estimated 41% of population, will support nationwide efforts to control TB - QIAGEN marks World TB Day 2014 on March 24 with QuantiFERON-TB...

2014-02-13 08:30:51

MOSCOW, February 13, 2014 /PRNewswire/ -- Russian and Korean biotech companies Infectex Ltd. [http://www.infectex.ru/?ln=en ] and Qurient Ltd. [http://maxwellbiotech.com ] have announced a license agreement granting Infectex exclusive rights to develop and commercialize Qurient's Tuberculosis-fighting drug Q203 in the Russian Federation, Armenia, Azerbaijan, Belarus, Kazakhstan, Kyrgyzstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan and Ukraine. (Logo:...

2014-02-04 12:27:12

Multi-year grant brings together non-profits, government, academia and the pharmaceutical industry to study pressing public health challenge TUCSON, Ariz., Feb. 4, 2014 /PRNewswire-USNewswire/ -- The Critical Path Institute, an independent, non-profit that catalyzes innovative ideas that accelerate the speed of drug and medical product development, today announced it has received a three-year grant from the Bill & Melinda Gates Foundation. The grant will be used to develop...

2014-01-28 23:04:15

Aim to Improve Care for HIV Patients in Irkutsk, Halt Growing Health Threat Charlottesville, VA (PRWEB) January 28, 2014 Researchers at the University of Virginia School of Medicine and colleagues in Russia are launching an ambitious effort to check the growing public health threat posed by drug-resistant tuberculosis, especially to people with HIV, in the Siberian city of Irkutsk. It’s a critically important mission, both for the people there and because of the risk that international...

2014-01-23 11:29:46

A major trial aiming to cut the rate of tuberculosis (TB) among South Africa's gold miners did not reduce the number of cases or deaths from the disease, according to a study published in the New England Journal of Medicine. Researchers from the London School of Hygiene & Tropical Medicine say that the results demonstrate the scale of the TB problem in South African gold mines, and highlight the need for a "combination prevention" approach to improve TB control. The TB epidemic in...

2013-11-25 08:28:22

TOKYO, Nov. 25, 2013 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito, "Eisai") announced today that it has become a signatory to the Tuberculosis Drug Accelerator (TBDA) partnership, a groundbreaking initiative that aims to speed up the discovery of essential new treatments for tuberculosis (TB). (Logo: http://photos.prnewswire.com/prnh/20120413/MM87168LOGO ) Jointly launched in June 2012 through a collaborative agreement among seven...